Aileron Therapeutics, Inc.
ALRN
Revenue
0.00
0.000.00%
3 Months ChangeAssets
109.40M
▲10.21M▲10.29%
3 Months ChangeLiabilities
8.38M
▲521.00k▲6.63%
3 Months ChangeFree Cash Flow
-6.56M
▲1.07M▲13.99%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-21
Form 8-K
ID: 0001193125-24-204425
2024-08-14
Form 8-K
ID: 0001193125-24-200739
2024-08-14
Form 10-Q
ID: 0000950170-24-097199
2024-07-26
Form 8-K
ID: 0001193125-24-186279
2024-06-05
Form 8-K
ID: 0001193125-24-154675
2024-05-16
Form 8-K
ID: 0001193125-24-140688
2024-05-15
Form 8-K
ID: 0001193125-24-139510
2024-05-15
Form 10-Q
ID: 0000950170-24-060583
2024-05-01
Form 8-K
ID: 0001193125-24-127657
2024-05-01
Form 8-K
ID: 0001193125-24-126425